[SCHEDULE 13G] iBio, Inc. SEC Filing
Point72 entities and Steven A. Cohen reported beneficial ownership of 14,289,118 shares of iBio, Inc. common stock, representing 9.9% of the outstanding class as of August 22, 2025. The reported position includes 14,280,000 shares issuable upon exercise of warrants, but those warrants are subject to a 9.99% exercise blocker so some warrants are not currently exercisable.
The filing states Point72 Asset Management, Point72 Capital Advisors and Mr. Cohen share voting and dispositive power over the reported shares through Point72 Associates and related arrangements. The cover pages and Item 4 disclose shared voting and dispositive power only; none of the reporting persons claim sole voting or dispositive power over the reported shares.
Entit脿 di Point72 e Steven A. Cohen hanno dichiarato la propriet脿 beneficiaria di 14.289.118 azioni ordinarie di iBio, Inc., pari al 9,9% della classe in circolazione al 22 agosto 2025. La posizione segnalata comprende 14.280.000 azioni suscettibili di essere emesse mediante l'esercizio di warrant; tuttavia tali warrant sono soggetti a un blocco all'esercizio del 9,99%, quindi alcuni warrant non sono attualmente esercitabili.
La comunicazione indica che Point72 Asset Management, Point72 Capital Advisors e il sig. Cohen condividono il potere di voto e il potere di disposizione sulle azioni segnalate tramite Point72 Associates e accordi collegati. Le pagine di copertina e l'Elemento 4 riportano esclusivamente un potere di voto e di disposizione condiviso; nessuna delle persone che hanno effettuato la segnalazione dichiara potere di voto o di disposizione esclusivo sulle azioni indicate.
Entidades de Point72 y Steven A. Cohen informaron la titularidad beneficiaria de 14.289.118 acciones ordinarias de iBio, Inc., que representan el 9,9% de la clase en circulaci贸n a fecha 22 de agosto de 2025. La posici贸n comunicada incluye 14.280.000 acciones que podr铆an emitirse mediante el ejercicio de warrants; no obstante, dichos warrants est谩n sujetos a un bloqueo de ejercicio del 9,99%, por lo que algunos warrants no son actualmente ejercitables.
La presentaci贸n indica que Point72 Asset Management, Point72 Capital Advisors y el Sr. Cohen comparten el poder de voto y el poder de disposici贸n sobre las acciones informadas a trav茅s de Point72 Associates y acuerdos relacionados. Las p谩ginas de portada y el Punto 4 divulgan 煤nicamente un poder de voto y de disposici贸n compartido; ninguna de las personas informantes reclama poder de voto o de disposici贸n exclusivo sobre las acciones reportadas.
Point72 甏�霠� 旮瓣磤霌り臣 鞀ろ嫲敫� A. 旖旐棬鞚� 2025雲� 8鞗� 22鞚� 旮办 iBio, Inc. 氤错喌欤� 14,289,118欤�(氚滍枆 欤检嫕鞚� 9.9%)鞐� 雽�頃� 靾橃澋鞝� 靻岇湢甓岇潉 鞁犼碃頄堨姷雼堧嫟. 鞁犼碃霅� 韽靺橃棎電� 鞗岆煱韸� 頄夓偓 鞁� 氚滍枆霅� 靾� 鞛堧姅 14,280,000欤缄皜 韽暔霅橃柎 鞛堨溂雮�, 頃措嫻 鞗岆煱韸鸽摛鞚� 9.99% 頄夓偓 彀嫧 臁办箻鞚� 雽�靸侅澊鞏挫劀 鞚茧秬 鞗岆煱韸鸽姅 順勳灛 頄夓偓頃� 靾� 鞐嗢姷雼堧嫟.
鞁犼碃靹滌棎 霐半ゴ氅� Point72 Asset Management, Point72 Capital Advisors鞕� 旖旐棬 鞌姅 Point72 Associates 氚� 甏�霠� 鞎届爼霌れ潉 韱淀暣 鞁犼碃霅� 欤检嫕鞐� 雽�頃� 鞚橁舶甓� 氚� 觳橂秳甓岇潉 瓿惦彊鞙茧 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 響滌 韼橃澊歆�鞕� 頃 4電� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岆鞚� 瓿奠嫓頃橁碃 鞛堨溂氅�; 鞁犼碃鞚� 欷� 鞏措姁 雸勱惮霃� 氤搓碃霅� 欤检嫕鞐� 雽�頃� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 欤检灔頃橃 鞎婌姷雼堧嫟.
Des entit茅s de Point72 et Steven A. Cohen ont d茅clar茅 la propri茅t茅 b茅n茅ficiaire de 14 289 118 actions ordinaires d'iBio, Inc., repr茅sentant 9,9 % de la cat茅gorie en circulation au 22 ao没t 2025. La position d茅clar茅e comprend 14 280 000 actions susceptibles d'锚tre 茅mises 脿 l'exercice de bons de souscription (warrants) ; toutefois ces warrants sont soumis 脿 une limitation d'exercice de 9,99 %, de sorte que certains warrants ne sont pas actuellement exer莽ables.
Le d茅p么t indique que Point72 Asset Management, Point72 Capital Advisors et M. Cohen partagent le pouvoir de vote et le pouvoir de disposition sur les actions d茅clar茅es via Point72 Associates et des accords connexes. Les pages de couverture et la rubrique 4 divulguent uniquement un pouvoir de vote et de disposition partag茅 ; aucune des personnes d茅clarantes ne pr茅tend d茅tenir seul le pouvoir de vote ou de disposition sur les actions signal茅es.
Einheiten von Point72 und Steven A. Cohen meldeten das wirtschaftliche Eigentum an 14.289.118 Stammaktien von iBio, Inc., was 9,9 % der ausstehenden Klasse zum 22. August 2025 entspricht. Die gemeldete Position umfasst 14.280.000 Aktien, die bei Aus眉bung von Warrants ausgegeben w眉rden; diese Warrants unterliegen jedoch einer Aus眉bungs-Sperre von 9,99 %, sodass einige Warrants derzeit nicht aus眉bbar sind.
In der Meldung hei脽t es, dass Point72 Asset Management, Point72 Capital Advisors und Mr. Cohen 眉ber Point72 Associates und damit verbundene Vereinbarungen Stimm- und Verf眉gungsgewalt 眉ber die gemeldeten Aktien teilen. Die Titelseiten und Punkt 4 geben lediglich ein geteiltes Stimm- und Verf眉gungsrecht an; keiner der meldenden Personen erhebt Anspruch auf alleiniges Stimm- oder Verf眉gungsrecht an den gemeldeten Aktien.
- Concentrated economic interest: A near-10% position (14,289,118 shares) signals material investor engagement with iBio.
- Transparency: Filing discloses warrant exposure (14,280,000 shares) and the 9.99% blocker, clarifying exercisability limits.
- Limited immediate control: All reported power is shared; reporting persons claim no sole voting or dispositive power.
- Warrant exercisability constrained: The 9.99% blocker prevents full immediate conversion of warrants, reducing potential influence.
Insights
TL;DR: Point72 reports a near-10% position in iBio largely via exercisable warrants, but a 9.99% blocker limits immediate additional ownership.
Point72's disclosed position of 14,289,118 shares (9.9%) is significant for a single reporting group and signals meaningful economic and governance interest without crossing the 10% threshold that would change regulatory implications. The inclusion of 14,280,000 shares tied to warrants means much of the position is contingent on exercise conditions and the 9.99% blocker reduces potential immediate dilution or ownership concentration. For investors, this is notable ownership disclosure but not an outright control shift.
TL;DR: Shared voting and dispositive power across Point72 entities and Mr. Cohen indicates coordinated control but avoids sole-control classifications.
The filing documents shared voting and dispositive authority rather than sole control, and includes a Joint Filing Agreement. The 9.99% blocker is a material structural limitation that prevents the reporting persons from exercising warrants to exceed the 9.99% threshold, affecting proxy and control dynamics. This preserves the issuer's existing control distribution while making Point72 a prominent stakeholder.
Entit脿 di Point72 e Steven A. Cohen hanno dichiarato la propriet脿 beneficiaria di 14.289.118 azioni ordinarie di iBio, Inc., pari al 9,9% della classe in circolazione al 22 agosto 2025. La posizione segnalata comprende 14.280.000 azioni suscettibili di essere emesse mediante l'esercizio di warrant; tuttavia tali warrant sono soggetti a un blocco all'esercizio del 9,99%, quindi alcuni warrant non sono attualmente esercitabili.
La comunicazione indica che Point72 Asset Management, Point72 Capital Advisors e il sig. Cohen condividono il potere di voto e il potere di disposizione sulle azioni segnalate tramite Point72 Associates e accordi collegati. Le pagine di copertina e l'Elemento 4 riportano esclusivamente un potere di voto e di disposizione condiviso; nessuna delle persone che hanno effettuato la segnalazione dichiara potere di voto o di disposizione esclusivo sulle azioni indicate.
Entidades de Point72 y Steven A. Cohen informaron la titularidad beneficiaria de 14.289.118 acciones ordinarias de iBio, Inc., que representan el 9,9% de la clase en circulaci贸n a fecha 22 de agosto de 2025. La posici贸n comunicada incluye 14.280.000 acciones que podr铆an emitirse mediante el ejercicio de warrants; no obstante, dichos warrants est谩n sujetos a un bloqueo de ejercicio del 9,99%, por lo que algunos warrants no son actualmente ejercitables.
La presentaci贸n indica que Point72 Asset Management, Point72 Capital Advisors y el Sr. Cohen comparten el poder de voto y el poder de disposici贸n sobre las acciones informadas a trav茅s de Point72 Associates y acuerdos relacionados. Las p谩ginas de portada y el Punto 4 divulgan 煤nicamente un poder de voto y de disposici贸n compartido; ninguna de las personas informantes reclama poder de voto o de disposici贸n exclusivo sobre las acciones reportadas.
Point72 甏�霠� 旮瓣磤霌り臣 鞀ろ嫲敫� A. 旖旐棬鞚� 2025雲� 8鞗� 22鞚� 旮办 iBio, Inc. 氤错喌欤� 14,289,118欤�(氚滍枆 欤检嫕鞚� 9.9%)鞐� 雽�頃� 靾橃澋鞝� 靻岇湢甓岇潉 鞁犼碃頄堨姷雼堧嫟. 鞁犼碃霅� 韽靺橃棎電� 鞗岆煱韸� 頄夓偓 鞁� 氚滍枆霅� 靾� 鞛堧姅 14,280,000欤缄皜 韽暔霅橃柎 鞛堨溂雮�, 頃措嫻 鞗岆煱韸鸽摛鞚� 9.99% 頄夓偓 彀嫧 臁办箻鞚� 雽�靸侅澊鞏挫劀 鞚茧秬 鞗岆煱韸鸽姅 順勳灛 頄夓偓頃� 靾� 鞐嗢姷雼堧嫟.
鞁犼碃靹滌棎 霐半ゴ氅� Point72 Asset Management, Point72 Capital Advisors鞕� 旖旐棬 鞌姅 Point72 Associates 氚� 甏�霠� 鞎届爼霌れ潉 韱淀暣 鞁犼碃霅� 欤检嫕鞐� 雽�頃� 鞚橁舶甓� 氚� 觳橂秳甓岇潉 瓿惦彊鞙茧 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 響滌 韼橃澊歆�鞕� 頃 4電� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岆鞚� 瓿奠嫓頃橁碃 鞛堨溂氅�; 鞁犼碃鞚� 欷� 鞏措姁 雸勱惮霃� 氤搓碃霅� 欤检嫕鞐� 雽�頃� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 欤检灔頃橃 鞎婌姷雼堧嫟.
Des entit茅s de Point72 et Steven A. Cohen ont d茅clar茅 la propri茅t茅 b茅n茅ficiaire de 14 289 118 actions ordinaires d'iBio, Inc., repr茅sentant 9,9 % de la cat茅gorie en circulation au 22 ao没t 2025. La position d茅clar茅e comprend 14 280 000 actions susceptibles d'锚tre 茅mises 脿 l'exercice de bons de souscription (warrants) ; toutefois ces warrants sont soumis 脿 une limitation d'exercice de 9,99 %, de sorte que certains warrants ne sont pas actuellement exer莽ables.
Le d茅p么t indique que Point72 Asset Management, Point72 Capital Advisors et M. Cohen partagent le pouvoir de vote et le pouvoir de disposition sur les actions d茅clar茅es via Point72 Associates et des accords connexes. Les pages de couverture et la rubrique 4 divulguent uniquement un pouvoir de vote et de disposition partag茅 ; aucune des personnes d茅clarantes ne pr茅tend d茅tenir seul le pouvoir de vote ou de disposition sur les actions signal茅es.
Einheiten von Point72 und Steven A. Cohen meldeten das wirtschaftliche Eigentum an 14.289.118 Stammaktien von iBio, Inc., was 9,9 % der ausstehenden Klasse zum 22. August 2025 entspricht. Die gemeldete Position umfasst 14.280.000 Aktien, die bei Aus眉bung von Warrants ausgegeben w眉rden; diese Warrants unterliegen jedoch einer Aus眉bungs-Sperre von 9,99 %, sodass einige Warrants derzeit nicht aus眉bbar sind.
In der Meldung hei脽t es, dass Point72 Asset Management, Point72 Capital Advisors und Mr. Cohen 眉ber Point72 Associates und damit verbundene Vereinbarungen Stimm- und Verf眉gungsgewalt 眉ber die gemeldeten Aktien teilen. Die Titelseiten und Punkt 4 geben lediglich ein geteiltes Stimm- und Verf眉gungsrecht an; keiner der meldenden Personen erhebt Anspruch auf alleiniges Stimm- oder Verf眉gungsrecht an den gemeldeten Aktien.
FAQ
How many iBio (IBIO) shares does Point72 report owning?
Does the filing include warrants in the reported position?
What is the 9.99% blocker mentioned in the filing?
Do Point72 or Steven A. Cohen have sole voting power over the reported shares?
Which Point72 entities filed the Schedule 13G for IBIO?
